BETTER DIAGNOSTIC TESTS ARE TRANSFORMING AND GUIDING EVERY ASPECT OF DECISION-MAKING IN ALL STAGES OF HEALTHCARE—PREVENTION, DETECTION, DIAGNOSIS, TREATMENT, AND MANAGEMENT, PARTICULARLY FOR PATIENTS WITH CANCER OR GENETIC DISEASES.

Our Company

Founded in 2008, Philip D. Cotter, PhD and Mathew W. Moore, PhD established ResearchDx as the first novel diagnostics business model that integrates and manages all diagnostic development and expertise within a single organization. As a Custom Diagnostic Organization, our business model reduces an over-burdensome process by virtue of its organizational structure without competing interests and allows for consideration of emerging molecular technologies in the development process. As a wholly-owned subsidiary of ResearchDx, PacificDx underpins this business model by providing total clinical, pre-clinical, and biopharmaceutical testing support.

The PacificDx molecular and clinical laboratory is located at ResearchDx headquarters, 5 Mason Drive, Irvine California. Please visit Our Lab page to learn more about our fully accredited and licensed high-complexity laboratory. Visit our Testing Services page for an overview of our services. If you have a specific need that you don’t see, please call us at 949.812.6944.

Better diagnostic tests are transforming and guiding every aspect of decision-making in all stages of healthcare—prevention, detection, diagnosis, disease prediction, treatment and therapeutic monitoring and management, particularly for patients with cancer or genetic diseases. As a premier molecular-specialty laboratory, PacificDx offers access to the most current and advanced genomic technologies and testing services.